Lilly cancer drug fares well in late-stage study
Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone.
Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone.
European regulators have approved a long-lasting insulin from Eli Lilly and Co. and German drugmaker Boehringer Ingelheim that is the subject of patent-infringement litigation with French rival Sanofi.
The U.S. Department of Health and Human Services is sending Indiana money to help the state's health care plan navigators sign up more residents through a federally run exchange.
Conservatives, after waging war on Obamacare, including its large expansion of Medicaid, are starting to try to propose alternative, conservative ways to achieve its key goals.
Companion Diagnostics Inc., a biotech company that relocated to Indiana from Connecticut in 2010, has entered bankruptcy reorganization while it tries to develop a therapy for inflammation.
The full U.S. Court of Appeals will rehear a case on Obamacare tax subsidies, granting a government request in a move that may reduce chances of a new Supreme Court showdown over a central part of the law.
When Hoosiers start shopping on the Obamacare exchanges again in November, they’ll find new, lower-priced competitors and modest price increases that are much lower than insurers initially proposed. But that doesn’t mean they’ll save money.
Indiana does not appear to be enjoying the rest of the nation’s slowdown in health care spending. Year-to-year growth in Indiana hit 6 percent in 2012 versus 4.5 percent for the nation.
The Indianapolis-based drugmaker said Thursday that peglispro produced statistically significant lower blood sugar levels in patients when compared to people who took the Sanofi insulin Lantus in two late-stage studies of people with type 1 diabetes.
Marian University, St. Vincent Health and four amateur sports groups have entered into formal discussions that could result in major developments at the northwest-side campus, the university announced Tuesday.
Just three months before the parent company of AIT Laboratories was sold in 2009 to its employees for $90 million, it was appraised for $17.1 million, according to a U.S. Department of Labor lawsuit.
Officials say Indiana residents will have more than triple the number of health insurance plans to choose from when the federal insurance exchange enrollment period starts in November. A a 5-percent average increase in exchange premiums is expected.
Takeda Pharmaceutical Co. and Eli Lilly and Co. lost a bid to have a judge throw out a combined $9 billion punitive-damage award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine.
The Indiana Blood Center is set to lose more than one-third of its revenue early next year, as three hospital systems bolt for cheaper prices offered by the American Red Cross.
Indiana has 58 percent more nursing homes per resident and spends an extra $1 billion per year on care in nursing homes than the average for the rest of the country.
Thanks to $40,000 donated by the Indianapolis Colts, USA Football’s Heads Up Football safety program will be offered to all Indiana high school football coaches in 2015.
Anthem patients in five U.S. cities, including Indianapolis, spent $220 less per MRI scan after Anthem told them of lower-cost facilities. In response, hospital-owned MRI facilities cut their prices.
Franciscan Alliance, which operates three hospitals in the Indianapolis area, is seeing fewer patients this year but is making more money due to expense cuts.
Dr. William VanNess said Friday he plans to stay on the job until Gov. Pence finds a replacement, saying he likely will stay on until early October.
Mainstreet Property Group, already the fastest-growing company in the Indianapolis area, now has the fuel it needs to nearly triple its pace of construction of senior care facilities around the country.